FRONTAGE (01521) Schedules 30 Mar 2026 Board Meeting to Review FY 2025 Results and Final Dividend Proposal

Bulletin Express

Mar 17

FRONTAGE HOLDINGS CORPORATION (stock code: 01521) has announced that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:

• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. • Considering a recommendation for a final dividend, subject to board approval.

The notification, dated 17 March 2026, was signed by Chairman Dr. Song Li on behalf of the board. The current board comprises three executive directors—Dr. Song Li, Dr. Wentao Zhang and Dr. Zhongping Lin—two non-executive directors—Ms. Zhuan Yin and Mr. Hao Wu—and three independent non-executive directors—Mr. Yifan Li, Mr. Erh Fei Liu and Dr. Jingsong Wang.

Investors will receive clarity on the company’s FY 2025 financial performance and any potential final dividend following the board’s deliberations on the stated date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1101991365"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101991365\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101991365?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101991365","market":"us","top_or_hot":-1,"title":"FRONTAGE (01521) Schedules 30 Mar 2026 Board Meeting to Review FY 2025 Results and Final Dividend Proposal","media":"Bulletin Express","content":"<p>FRONTAGE HOLDINGS CORPORATION (stock code: 01521) has announced that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for a final dividend, subject to board approval.</p>\n<p>The notification, dated 17 March 2026, was signed by Chairman Dr. Song Li on behalf of the board. The current board comprises three executive directors—Dr. Song Li, Dr. Wentao Zhang and Dr. Zhongping Lin—two non-executive directors—Ms. Zhuan Yin and Mr. Hao Wu—and three independent non-executive directors—Mr. Yifan Li, Mr. Erh Fei Liu and Dr. Jingsong Wang.</p>\n<p>Investors will receive clarity on the company’s FY 2025 financial performance and any potential final dividend following the board’s deliberations on the stated date.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FRONTAGE (01521) Schedules 30 Mar 2026 Board Meeting to Review FY 2025 Results and Final Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFRONTAGE (01521) Schedules 30 Mar 2026 Board Meeting to Review FY 2025 Results and Final Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-17 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>FRONTAGE HOLDINGS CORPORATION (stock code: 01521) has announced that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:</p>\n<p>• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for a final dividend, subject to board approval.</p>\n<p>The notification, dated 17 March 2026, was signed by Chairman Dr. Song Li on behalf of the board. The current board comprises three executive directors—Dr. Song Li, Dr. Wentao Zhang and Dr. Zhongping Lin—two non-executive directors—Ms. Zhuan Yin and Mr. Hao Wu—and three independent non-executive directors—Mr. Yifan Li, Mr. Erh Fei Liu and Dr. Jingsong Wang.</p>\n<p>Investors will receive clarity on the company’s FY 2025 financial performance and any potential final dividend following the board’s deliberations on the stated date.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01521","symbol_name":"方达控股","start_time":0,"source_url":"","article_id":"1101991365","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101991365","pubTimestamp":1773738263,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"FRONTAGE HOLDINGS CORPORATION (stock code: 01521) has announced that its board of directors will convene on 30 March 2026. The meeting’s agenda includes: • Reviewing and approving the consolidated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01521":"方达控股"},"translate_title":"方达(01521)安排2026年3月30日董事会会议审阅2025财年业绩及末期股息建议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01521":1},"content_text":"FRONTAGE HOLDINGS CORPORATION (stock code: 01521) has announced that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:\n• Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.  \n• Considering a recommendation for a final dividend, subject to board approval.\nThe notification, dated 17 March 2026, was signed by Chairman Dr. Song Li on behalf of the board. The current board comprises three executive directors—Dr. Song Li, Dr. Wentao Zhang and Dr. Zhongping Lin—two non-executive directors—Ms. Zhuan Yin and Mr. Hao Wu—and three independent non-executive directors—Mr. Yifan Li, Mr. Erh Fei Liu and Dr. Jingsong Wang.\nInvestors will receive clarity on the company’s FY 2025 financial performance and any potential final dividend following the board’s deliberations on the stated date.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}